Page 196 - 80 guidelines for the treatment of malaria_opt

nd
Guidelines for the treatment of malaria – 2 edition

16. Farcas GA et al. Evaluation of the Binax NOW ICT test versus polymerase chain reaction
and microscopy for the detection of malaria in returned travelers. American Journal of
Tropical Medicine and Hygiene, 2003, 69:589–592.
17. Figueiredo FAF et al. Performance of an immunochromatography test for vivax malaria
in the Amazon region, Brazil. Revista de Saúde Pública, 2003, 37:390–392.
18. Forney JR et al. Devices for rapid diagnosis of malaria: evaluation of prototype assays that
detect Plasmodium falciparum histidine-rich protein 2 and a Plasmodium vivax-specific
antigen. Journal of Clinical Microbiology, 2003, 41:2358–2366.
19. Kolaczinski J et al. Comparison of the OptiMAL rapid antigen test with field microscopy
for the detection of Plasmodium vivax and P. falciparum: considerations for the application
of the rapid test in Afghanistan. Annals of Tropical Medicine and Parasitology, 2004,
98:15–20.
20. United Nations Children’s Fund (UNICEF)/United Nations Development Programme
(UNDP)/World Bank/World Health Organization (WHO) Special Programme for Research
& Training in Tropical Diseases (TDR). Malaria rapid diagnostic test performance: results
of WHO product testing of malaria RDTs: round 1. Geneva, WHO, 2008 (http://www.
finddiagnostics.org/resource-centre/reports_brochures/malaria-diagnostics-report-2009.
html (accessed 27 October 2009).
21. Myint HY et al. A systematic overview of published antimalarial drug trials. Transactions
of the Royal Society of Tropical Medicine and Hygiene, 2004, 98: 73–81.
22. Fryauff DJ et al. Survey of in vivo sensitivity to chloroquine by Plasmodium falciparum
and P. vivax in Lombok, Indonesia. American Journal of Tropical Medicine and Hygiene,
1997, 56:241–244.
23. Silachamroon U et al. Clinical trial of oral artesunate with or without high-dose primaquine
for the treatment of vivax malaria in Thailand. American Journal of Tropical Medicine and
Hygiene, 2003, 69:14–18.
24. Baird JK, Rieckmann KH. Can primaquine therapy for vivax malaria be improved? Trends
in Parasitology, 2003, 19:115–120.
25. Villalobos-Salcedo JM et al. In-vivo sensitivity of Plasmodium vivax isolates from Rond
nia (western Amazon region, Brazil) to regimens including chloroquine and primaquine.
Annals of Tropical Medicine and Parasitology, 2000, 94:749–758.
26. Gogtay NJ et al. Efficacies of 5- and 14-day primaquine regimens in the prevention of
relapses in Plasmodium vivax infections. Annals of Tropical Medicine and Parasitology,
1999, 93:809–812.
27. Schwartz E, Regev-Yochay G, Kurnik D. Short report: a consideration of primaquine dose
adjustment for radical cure of Plasmodium vivax malaria. American Journal of Tropical
Medicine and Hygiene, 2000, 62:393–395.
28. Tjitra E et al. Randomized comparative study of chloroquine and halofantrine in vivax
malaria patients. Medical Journal of Indonesia, 1995, 4:30–36.
29. Baird JK et al. Treatment of chloroquine-resistant Plasmodium vivax with chloroquine and
primaquine or halofantrine. Journal of Investigative Dermatology, 1995, 171:1678–1682.

182